Adovate
Schuyler V. is currently serving as the Vice President of Development at Adovate. Prior to this role, Schuyler held various senior positions in clinical and regulatory operations at companies such as Adial Pharmaceuticals, Krystal Biotech, and Intrexon Corporation. With a Bachelor's degree in Biology from George Mason University, Schuyler has a strong background in the pharmaceutical industry, having worked in positions ranging from Project Manager to Sr. Regulatory Specialist at companies like INC Research, New River Pharmaceuticals, and Quintiles.
This person is not in any teams
Adovate
Adovate develops novel drugs that target adenosine receptors involved in major diseases. These drug candidates have been created using our next-generation adenosine drug development platform, which enable design of patented compounds with favorable physiochemical characteristics and distribution kinetics that historically limited drugs acting against the adenosine receptors.